Peter Kurzweil, MD
Orthopedic Surgery · Long Beach, CANPI 1700865466
Payments from drug & device makers
What this record shows
This record is dominated by ownership interests: $425,863 of the $494,119 with a category attached, or 86.2%. Anika Therapeutics, Inc. accounts for 97.5% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2020 at $428,105 and has fallen 100.0% since, to $15 in 2024. Among orthopedic surgery clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 91 payments — averaging $5429.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Anika Therapeutics, Inc.$482K
- Smith+Nephew$10K
- Dunamis Medical, LLC$510
- Pacira Therapeutics, Inc.$453
- Amgen$437
- Stryker$299
- plus $354 from 4 others
What the payments were for
- Consulting fees$2,4751%
- Speaking & faculty fees$7,7002%
- Food & beverage$2,3270%
- Ownership interest$425,86386%
- Other$55,75411%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Anika Therapeutics, Inc. | 4 | $481,617 |
| Smith+Nephew | 10 | $10,450 |
| Dunamis Medical, LLC | 1 | $510 |
| Pacira Therapeutics, Inc. | 24 | $453 |
| Amgen | 34 | $437 |
| Stryker | 4 | $299 |
| Johnson & Johnson | 8 | $150 |
| Miach Orthopaedics, Inc. | 1 | $102 |
| Pacira Pharmaceuticals Incorporated | 4 | $86 |
| Linvatec Corporation | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NOVOSTITCH$8,650
- Fast-Fix 360$4,250
- MAKO$237
- Meniscal Root Repair System$125
- Meniscus Mender II$125
How this compares
$494,119 in reported general payments places this provider in the 95th percentile of 130 orthopedic surgery providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 123 | $3,764 |
| Meloxicam | 519 | $1,351 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 91 | $1,191 |
| Cephalexin | 104 | $568 |
| Diclofenac Sodium | 25 | $383 |
| Ibuprofen | 13 | $251 |
| Omeprazole | 64 | $238 |
| Diclofenac Sodium ErDiclofenac Sodium | 17 | $215 |
| Prednisone | 74 | $203 |
| Gabapentin | 18 | $65 |
| Tramadol Hcl | 11 | $33 |
Paid to pharmacies, not to this prescriber.
Other orthopedic surgery in Long Beach
- Phillip YuanLong Beach$60K
- Jesse CaballeroLong Beach$8K
- William WardenLong Beach$2K
- Albert TsaiLong Beach$2K
- Marshall ChingOroville$17.8M
- Ran SchwarzkopfOrange$2M
- Brian ChingOroville$1.4M
- Scott Hackerla Mesa$434K
- Richard NussbaumSherman Oaks$238K
- William KimTorrance$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.